The Relative Strength (RS) Rating for AdaptHealth climbed into a higher percentile Friday, as it got a lift from 69 to 76.
This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the best stocks tend to have an RS Rating north of 80 as they launch their largest runs. See if AdaptHealth can continue to show renewed price strength and hit that benchmark.
Can You Really Time The Stock Market?
AdaptHealth is working on a consolidation with an 11.90 buy point. See if it can clear the breakout price in heavy volume.
The company posted 0% EPS growth in its most recent report, while sales growth came in at 0%.
The company earns the No. 8 rank among its peers in the Medical-Outpatient/Home Care industry group. Addus HomeCare, Encompass Health and BrightSpring Hlth Svcs are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
